onclive· 2mo ago
save<![CDATA[HS-10504 Shows Promising Activity in EGFR C797S–Mutant NSCLC After TKI Resistance]]>
May 5, 2026read original ↗
<![CDATA[Phase 1 data show HS-10504 yields encouraging responses and manageable safety in EGFR C797S–mutant NSCLC post TKI therapy.]]>
Full text isn't available here yet — read it at onclive.
read full article on onclive ↗🔗 mentioned in this article
no entities indexed yet
comments(0)
5-min edit window · permanent after that